Cytosorbents (CTSO) Interest Expenses (2011 - 2026)
Cytosorbents (CTSO) posted Interest Expenses of $8.0 million for Q1 2026, up 324.87% on a QoQ basis from $1.9 million in Q4 2025, and up 1368.06% year-over-year from $544664.0 in Q1 2025.
Cytosorbents (CTSO) Interest Expenses (2011 - 2026) Analysis & Trends
Cytosorbents' Interest Expenses history runs 15 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- Quarterly Interest Expenses rose 1368.06% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (up 371.55% YoY) and the FY2025 annual result came in at $52.9 million, up 9.5% from the prior year.
- Interest Expenses was $8.0 million for Q1 2026 at Cytosorbents, up from $1.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $21.6 million in Q2 2025 and bottomed at $100000.0 in Q2 2024.
- A 5-year average of $2.9 million and a median of $685000.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses plunged 98.32% — and 2025, when it surged 21498.0%.
- Cytosorbents' Interest Expenses stood at $2.9 million in 2022, then tumbled by 79.49% to $602025.0 in 2023, then decreased by 25.42% to $449000.0 in 2024, then soared by 319.15% to $1.9 million in 2025, then jumped by 324.87% to $8.0 million in 2026.
- Business Quant data shows CTSO's Interest Expenses at $8.0 million in Q1 2026, $1.9 million in Q4 2025, and $240000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 240,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 21.60 Mn |
| Jun 30, 2025 | 21.60 Mn |
| Mar 31, 2025 | 544,664.00 |
| Mar 31, 2025 | 544,664.00 |
| Dec 31, 2024 | 449,000.00 |
| Dec 31, 2024 | 449,000.00 |
| Sep 30, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 602,025.00 |
| Dec 31, 2023 | 602,025.00 |